Blue LED Light Attenuates the Bacterial Bioburden in Chronic Wounds Transiently but Dose-Dependently - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Blue LED Light on Reducing Bacterial Load in Chronic Wounds: A Dose-Dependent and Temporary Effect

  • By

  • Frederik Plum

  • Aqella Rasul

  • Ewa Anna Burian

  • Claus Henrik Nielsen

  • Khaled S. A. Ghathian

  • Magnus S. Ågren

  • Katrine E. Karmisholt

  • Klaus Kirketerp-Møller

  • July 1, 2026

Share

Clinical Report: Impact of Blue LED Light on Reducing Bacterial Load in Chronic Wounds

Overview

This study investigates the effects of blue LED light on bacterial load in chronic wounds, demonstrating a dose-dependent reduction in bacterial counts.

Background

Chronic wounds are a significant healthcare challenge, with a prevalence of 1% in Denmark and associated treatment costs of 2%-3% of the total healthcare budget. Effective antibacterial treatments are urgently needed to manage these wounds, as they create environments conducive to bacterial growth. Phototherapy, particularly using blue light, is being explored for its potential to promote wound healing and reduce bacterial load.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Blue light therapy at 405 nm can reduce bacterial growth in chronic wounds.
  • Three fluences of blue light (20, 60, and 100 J/cm2) were tested for their effects on bacterial counts and cytokine levels.
  • Daily treatments with blue LED light reduced bioburden by 0–1.3 log10 CFU/g after irradiation.
  • Blue light therapy may activate intracellular transcription factors and influence cytokine expression.
  • Shorter wavelengths of blue light are associated with increased cytotoxicity in human cells.

Clinical Implications

Healthcare professionals should consider the potential of blue LED light as an adjunctive therapy for chronic wounds, particularly in reducing bacterial load. Further studies are needed to establish optimal dosing and safety profiles for clinical use.

Conclusion

The study supports the use of blue LED light therapy as a promising approach to reduce bacterial load in chronic wounds, warranting further investigation into its clinical applications.

Related Resources & Content

  1. Halstead et al., The Journal of Infectious Diseases, 2023 -- An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model
  2. Rochelle Nataloni, Retinal Physician, 2024 -- Blue-light IOLs Reduce Progression of Macular Atrophy, But Not Incidence
  3. Mary Beth Versaci, ADA News, 2021 -- April JADA finds curing lights inhibit gingival epithelial cell growth
  4. American Diabetes Association, 2025 -- The American Diabetes Association Releases “Standards of Care in Diabetes—2026”
  5. Randomized clinical trial of the efficacy of the EmoLED medical device in the treatment of stage 2 and stage 3 pressure ulcers: The RISE_UP study - ScienceDirect
  6. Intensive Care Medicine — Efficacy of Blue Light-Blocking Glasses for Night Shift Healthcare Workers in ICUs During the COVID-19 Crisis
  7. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  8. Randomized clinical trial of the efficacy of the EmoLED medical device in the treatment of stage 2 and stage 3 pressure ulcers: The RISE_UP study - ScienceDirect
  9. Clinical dosimetry and efficacy of LED photobiomodulation for chronic lower-limb wound healing: a systematic review of randomized trials - PubMed

Original Source(s)

Related Content